Verxant 150 mg/1 mL Injection Pen containing Secukinumab is a high-quality biologic medication developed to treat various inflammatory conditions. Verxant 150 mg/1 mL is primarily used for the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Verxant 150 mg/1 mL Injection Pen is designed for subcutaneous administration, ensuring accurate dosage with every application.
Verxant 150 mg/1 mL contains Secukinumab, an IL-17A inhibitor that specifically targets and blocks interleukin-17A, a cytokine involved in inflammatory responses. By inhibiting IL-17A, Verxant 150 mg/1 mL helps reduce inflammation, relieve symptoms, and improve the quality of life for patients suffering from autoimmune diseases.
Key Benefits and Uses of Verxant 150 mg/1 mL:
- Effective treatment for moderate to severe plaque psoriasis.
- Provides relief for patients with psoriatic arthritis.
- Reduces symptoms of ankylosing spondylitis.
- Subcutaneous injection ensures convenient and precise self-administration.
- Improves patient quality of life by reducing inflammation and skin lesions.
Dosage and Administration:
Verxant 150 mg/1 mL is administered via subcutaneous injection, typically under the skin of the thigh, upper arm, or abdomen. Dosage frequency and treatment duration depend on the patient’s condition and physician’s prescription. The pre-filled Verxant 150 mg/1 mL Injection Pen is designed for easy and safe self-injection.
Storage Instructions:
- Store Verxant 150 mg/1 mL Injection Pen in a refrigerator between 2°C and 8°C.
- Keep away from heat, sunlight, and freezing temperatures.
- Do not shake the pen.
Possible Side Effects:
While Verxant 150 mg/1 mL is generally well-tolerated, some patients may experience mild side effects, such as:
- Injection site reactions (redness, swelling, or pain).
- Headache.
- Nasopharyngitis (cold symptoms).
- Fatigue.
Serious side effects are rare but may include severe infections or allergic reactions. Consult a healthcare provider if any unusual symptoms occur.
Why Choose Verxant 150 mg/1 mL?
- Contains Secukinumab, a proven IL-17A inhibitor for treating autoimmune diseases.
- Trusted quality by Farmanova.
- User-friendly pre-filled injection pen.
- Recommended by healthcare professionals worldwide.
Product Contents:
Each box contains:
- 1 pre-filled Verxant 150 mg/1 mL Injection Pen with Secukinumab 150 mg solution.
Değerlendirmeler
Henüz değerlendirme yapılmadı.